-
Lycored Launches Video to Support Study Findings
Lycored, industry leaders in cultivating we...
-
Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
-
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
-
Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019, 24-25 September, Gdańsk (Poland)
-
Inaugural EU-MED Summit organized in partnership with the city of Lodz will drive innovation and bring new opportunities to the healthcare ecosystem
All articles
2014-12-05
Nucleolin as a target for anti-cancer therapy
Nucleolin, a multifunctional phosphoprotein present mainly in nucleolus, has drawn much attention of molecular biologists due to its role in carcinogenesis and potential of being attractive target for more efficient therapies. As current methods of cancer treatment are still highly unspecific, such a... Read more
Tags nucleolin , cancer , antibody , Bradford Goodwin , therapy
2013-11-04
